We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Worldwide Stent Sales Declining, Boston Scientific Earnings Affected
Worldwide Stent Sales Declining, Boston Scientific Earnings Affected
April 27, 2007
Boston Scientific's first-quarter results are "good enough," with implantable cardioverter-defibrillator (ICD) sales improving, but the company's drug-eluting stent sales "once again showedsignificant weakness," an RBC Capital Markets analyst report said.